4 Healthy TSX Index Dividend Stocks for a Low-Risk Investor

Long-term investors might want to buy the dip with Savaria Corp. (TSX:SIS), or consider a few other solid all-rounders on the TSX index.

With personal mobility stock Savaria (TSX:SIS) down 10.98% in the last five days at the time of writing, let’s see whether this otherwise healthy TSX index ticker is worth buying on the dip, along with three other Canadian stocks with strong all-round statistics and sturdy balance sheets.

Savaria

One of the top medical aid picks on the TSX index, Savaria is also one of the strongest all-rounders for a long-term investor. Specializing in personal mobility units, Savaria saw a positive one-year past earnings growth of 44.9% that’s more or less in line with its usual trajectory, as per a five-year average growth rate of 31.5%.

However, as Savaria insiders have only sold shares in the last three months, should investors buy into an overvalued stock with a P/E of 26.1 times earnings and P/B of three times book? Given its solid market share, a moderate dividend yield of 3.23%, and a decent 29.9% expected annual growth in earnings, there are at least three reasons why it might be a smart idea.

Manulife Financial (TSX:MFC)

Up 6.01% in the last five days and yet still deeply undervalued, with a discount of 46% against the future cash flow value, this stock is looking like a strong buy. With a market-beating P/E ratio of 9.6 times earnings and trading at book price, Manulife Financial is indeed something of a value investor’s dream right now – especially if that dream involves a 4.48% dividend yield and an 11.9% expected annual growth in earnings (which isn’t bad for a financials stock).

With more shares in Manulife Financial having been picked up than shed by insiders over the last three months in significant volumes, and with a one-year past earnings growth rate of 138.1% beating a slightly negative five-year average, it’s a solid stock on a tear.

Canadian Imperial Bank of Commerce (TSX:CM)(NYSE:CM)

Long-term buyers looking for a healthy TSX index stock have a solid contender here – a banker with a hearty balance sheet in common with the rest of the Big Six. More shares have been bought than sold by CIBC insiders over the last few months, and with a 1.38% gain in the last five days, it’s a popular choice.

In terms of profitability, a one-year past growth of 11.4% just edges past its five-year average of 10.8%, beating the Canadian banking averages for both periods (both of which are below 10%). CIBC is also decently valued, with a P/E of 9.8 times earnings and market-weight P/B. A dividend yield of 4.76% matched with a 3.8% expected annual growth in earnings provides the clincher.

TFI International (TSX:TFI)

Gaining 4.13% in the last five days, this trucking and transport ticker is a favourite of the TSX index, still coasting along on an impressive one-year earnings growth of 298.5% that leaves even its own five-year average of 23.4% in the dust.

While it carries debt of 96.2% of net worth, that debt is well-covered and represents a reduction over the last five years. Meanwhile, though a P/B of 2.3 times book is above the TSX index average, its P/E of 10.7 times earnings dovetails well with a moderate dividend yield of 2.37% and 5.4% expected annual growth in earnings.

The bottom line

A niche stock, Savaria is a possible value opportunity with its sturdy position in the personal mobility industry, and is also geographically diversified. While CIBC shines in terms of value and dividend, its outlook isn’t spectacularly positive, though it has this in common with the majority of other Canadian bankers. Manulife Financial looks like another strong buy, while TFI International would add diversification to an energy- and financials-heavy dividends portfolio.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

More on Dividend Stocks

hand stacks coins
Dividend Stocks

3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold for a Decade

These three high-yield dividend stocks still have some work to do, but each are in steady areas that are only…

Read more »

senior man and woman stretch their legs on yoga mats outside
Dividend Stocks

TFSA: 2 Canadian Stocks to Buy and Hold Forever

Here are 2 TFSA-worthy Canadian stocks. Which one is a good buy for your TFSA today?

Read more »

calculate and analyze stock
Dividend Stocks

This 5.5% Dividend Stock Pays Cash Every Single Month!

This REIT may offer monthly dividends, but don't forget about the potential returns in the growth industry its involved with.

Read more »

Silver coins fall into a piggy bank.
Dividend Stocks

How to Use Your TFSA to Earn up to $6,000 Per Year in Tax-Free Passive Income

A high return doesn't mean you have to make a high investment -- or a risky one -- especially with…

Read more »

path road success business
Dividend Stocks

2 High-Yield Dividend Stocks to Buy Hand Over Fist and 1 to Avoid

High yields are great and all, but only if returns come with them. And while two of these might, another…

Read more »

Man holds Canadian dollars in differing amounts
Dividend Stocks

This 7% Dividend Stock Pays Cash Every Month

A high dividend yield isn't everything. But when it pays out each month and offers this stability, it's worth considering!

Read more »

young people stare at smartphones
Dividend Stocks

GST/HST “Vacation”: Everything Canadians Need to Know

The GST/HST "vacation" is a little treat for the holidays, along with a $250 payment. What should you do with…

Read more »

Train cars pass over trestle bridge in the mountains
Dividend Stocks

Is CNR Stock a Buy, Sell, or Hold for 2025?

Can CNR stock continue its long-term outperformance into 2025 and beyond? Let's explore whether now is a good time to…

Read more »